Skip to main content

Regulatory & Access Resources

Browse our regulatory & access resources to find the latest articles, blogs, brochures, and videos from our experts. See the latest content below.

Preparing for the New Era of Hybrid Regulatory Inspections

The U.S. Food and Drug Administration (FDA) has long aimed to strengthen its use of remote inspection and integrate desk-based assessments with traditional on-site visits. The pandemic has dramatically accelerated that evolution. Welcome to the new era of hybrid pre-approval and pre-licensing inspection. What do you need to know?